share_log

UBS Maintains Buy on CareMax, Lowers Price Target to $6

Benzinga Real-time News ·  Jan 6, 2023 08:43

UBS analyst Andrew Mok maintains CareMax (NASDAQ:CMAX) with a Buy and lowers the price target from $10 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment